Circulating tumor necrosis factor-alpha production during the progression of rat endotoxic sepsis

被引:7
作者
Xuan, DW
Nicolau, DP
Nightingale, CH
Quintiliani, R
机构
[1] Hartford Hosp, Dept Pharm Res, Hartford, CT 06102 USA
[2] Hartford Hosp, Div Infect Dis, Hartford, CT 06102 USA
[3] Hartford Hosp, Off Res Adm, Hartford, CT 06102 USA
关键词
D O I
10.1159/000063221
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The endotoxin-mediated tumor necrosis factor-alpha (TNF-alpha) induction was investigated in a rat endotoxin septic shock model. Rats were challenged intravenously with lethal doses of endotoxin. Circulating endotoxin and TNF-alpha concentrations were measured over various times following endotoxin administration. A derivative of human immunoglobulin G, 5S-IgG, was administered at various times relative to endotoxin dosing to test its anti-endotoxin activity. Results showed that endotoxin challenge initiated substantial amounts of TNF-alpha release into the rat circulaton/system leading to death. Atemporal pattern of TNF-alpha increases following endotoxin administration was observed; the rat plasma TNF-alpha level rapidly increased 60 min after endotoxin injection, peaked around 120 min and returned to low levels by 240 min. A rapid clearance pattern of endotoxin was also observed in rats, 5S-IgG exhibited its moderate anti-endotoxin activity by partially suppressing the endotoxin-mediated TNF-alpha release and decreasing the overall mortality only when given before triggering of TNF-alpha induction. However, this inhibitory effect of 5S-IgG on endotoxin-mediated TNF-alpha release and the resultant protective effect against endotoxin lethality rapidly diminished when 5S-IgG was administered after the occurrence of TNF-alpha induction. Collectively, these results suggest that the timing of the anti-endotoxin treatment is critical in achieving its effectiveness and imply that the endotoxin levels after the onset of the cytokine cascade is of questionable significance. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:194 / 202
页数:9
相关论文
共 32 条
  • [1] BLICK M, 1987, CANCER RES, V47, P2986
  • [2] PLASMA ENDOTOXIN AS A PREDICTOR OF MULTIPLE ORGAN FAILURE AND DEATH IN SYSTEMIC MENINGOCOCCAL DISEASE
    BRANDTZAEG, P
    KIERULF, P
    GAUSTAD, P
    SKULBERG, A
    BRUUN, JN
    HALVORSEN, S
    SORENSEN, E
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1989, 159 (02) : 195 - 204
  • [3] PROGNOSTIC VALUES OF TUMOR-NECROSIS-FACTOR CACHECTIN, INTERLEUKIN-1, INTERFERON-ALPHA, AND INTERFERON-GAMMA IN THE SERUM OF PATIENTS WITH SEPTIC SHOCK
    CALANDRA, T
    BAUMGARTNER, JD
    GRAU, GE
    WU, MM
    LAMBERT, PH
    SCHELLEKENS, J
    VERHOEF, J
    GLAUSER, MP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (05) : 982 - 987
  • [4] THE NONSPECIFIC NATURE OF ENDOTOXIN TOLERANCE
    CAVAILLON, JM
    [J]. TRENDS IN MICROBIOLOGY, 1995, 3 (08) : 320 - 324
  • [5] EFFECT OF POLYMYXIN-B SULFATE ON ENDOTOXIN ACTIVITY IN A GRAM-NEGATIVE SEPTICEMIA MODEL
    CORRIGAN, JJ
    KIERNAT, JF
    [J]. PEDIATRIC RESEARCH, 1979, 13 (01) : 48 - 51
  • [6] CORRIGAN JJ, 1971, J LAB CLIN MED, V77, P802
  • [7] ENDOTOXEMIA IN HUMAN SEPTIC SHOCK
    DANNER, RL
    ELIN, RJ
    HOSSEINI, JM
    WESLEY, RA
    REILLY, JM
    PARILLO, JE
    [J]. CHEST, 1991, 99 (01) : 169 - 175
  • [8] PATTERNS OF CYTOKINES, PLASMA ENDOTOXIN, PLASMINOGEN-ACTIVATOR INHIBITOR, AND ACUTE-PHASE PROTEINS DURING THE TREATMENT OF SEVERE SEPSIS IN HUMANS
    DOFFERHOFF, ASM
    BOM, VJJ
    DEVRIESHOSPERS, HG
    VANINGEN, J
    VANDERMEER, J
    HAZENBERG, BPC
    MULDER, POM
    WEITS, J
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (02) : 185 - 192
  • [9] THE COMPLEX PATTERN OF CYTOKINES IN SEPSIS - ASSOCIATION BETWEEN PROSTAGLANDINS, CACHECTIN, AND INTERLEUKINS
    ERTEL, W
    MORRISON, MH
    WANG, P
    BA, ZF
    AYALA, A
    CHAUDRY, IH
    [J]. ANNALS OF SURGERY, 1991, 214 (02) : 141 - 148
  • [10] FREUDENBERG MA, 1984, REV INFECT DIS, V6, P483